Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial |
| |
| Authors: | Hansson Johan,Aamdal Steinar,Bastholt Lars,Brandberg Yvonne,Hernberg Micaela,Nilsson Bo,Stierner Ulrika,von der Maase Hans Nordic Melanoma Cooperative Group |
| |
| Affiliation: | Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. johan.hansson@ki.se |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
